We fully endorse the Editorial1 on the negative opinion of the European Medicines Agency of the use of lecanemab for the treatment of early Alzheimer's disease. Investigators from the European ...

A new interdisciplinary study at the University of Delaware seeks to study AD by examining changes in the arteries and brain ...

From happy moments to heartbreak, our phones' photo reminders might be messing with how we remember—and forget.

Researchers map the unique genetic regulation of proteins in human cerebrospinal fluid, identifying potential targets for ...

Alzheimer’s Clinical Data: High exposure at three significant Alzheimer ... clearance in 2020 as a portable magnetic resonance brain imaging device for producing images that display the internal ...

Galantamine slowed decline in cognitive function, functional ability, and behavior at 6 months in people with Alzheimer's ...

Join Overture Center on Tuesday, Dec. 3 for “Total Visibility,” an evening of dialogue, art and action focused on raising ...

That disease is Alzheimer’s disease. Let’s begin with some definitions. Alzheimer’s disease is a degenerative brain disease caused by complex brain changes following cell damage. Symptoms gradually ...

Study finds mosaicism in Down syndrome reduces Alzheimer's risk, providing new insights into genetic influences on cognitive ...